ULYSSESUltrasound Guided Venous Puncture for Safe Atrial Fibrillation Ablation
This study aims to evaluate the safety of using ultrasound-guided venous puncture for atrial fibrillation ablation by observing the occurrence of venous access site complications within 30 days after the procedure.
Ultrasound guided venous access during AF ablation
Diagnostic Study
Summary
Study start date: March 3, 2024
Actual date on which the first participant was enrolled.The study examines whether using ultrasound to guide venous puncture can make atrial fibrillation ablation procedures safer. Atrial fibrillation is a common heart rhythm disorder, and ablation is a treatment that helps restore normal heart rhythm. However, there can be risks associated with accessing veins during this procedure. By using ultrasound, doctors might be able to minimize complications at the access site, potentially leading to safer outcomes for patients undergoing this treatment. Participants in the study will undergo the standard ablation procedure, but with the added use of ultrasound to guide the needle when accessing veins. The study will observe and record if there are fewer complications, such as bleeding or bruising, at the site where the vein is accessed. The main focus is on determining whether ultrasound guidance can effectively reduce these risks, improving the overall safety of the procedure.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.1075 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location